Stock Research: IRadimed

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

IRadimed

NasdaqCM:IRMD US46266A1097
48
  • Value
    25
  • Growth
    93
  • Safety
    Safety
    31
  • Combined
    18
  • Sentiment
    100
  • 360° View
    360° View
    48
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

IRadimed Corporation develops, manufactures, markets and distributes MRI compatible medical devices and accessories. They operate in the medical devices industry. The company primarily sells its products to hospitals and acute care facilities. In the last fiscal year, the company had a market cap of $741 million, profits of $56 million, revenue of $73 million and 160 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 48 (better than 48% compared with alternatives), overall professional sentiment and financial characteristics for the stock IRadimed are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for IRadimed. The consolidated Growth Rank has a good rank of 93, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 93% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 100, which means that professional investors are more optimistic about the stock than for 100% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 31, which means that the share price of IRadimed is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 69% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 25, which means that the company has a financing structure that is riskier than those of 75% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
31 45 31 9
Growth
93 79 95 100
Safety
Safety
25 25 91 91
Sentiment
100 88 100 78
360° View
360° View
48 48 80 82
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
61 60 93 93
Opinions Change
100 50 89 50
Pro Holdings
n/a 92 80 84
Market Pulse
100 100 100 1
Sentiment
100 88 100 78
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
31 45 31 9
Growth
93 79 95 100
Safety Safety
25 25 91 91
Combined
18 18 97 97
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
19 24 17 21
Price vs. Earnings (P/E)
3 9 10 15
Price vs. Book (P/B)
23 25 12 26
Dividend Yield
90 92 94 1
Value
31 45 31 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
61 60 50 43
Profit Growth
57 35 94 76
Capital Growth
95 90 65 93
Stock Returns
91 75 95 99
Growth
93 79 95 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
100 79 100 100
Refinancing
21 26 31 35
Liquidity
1 1 62 62
Safety Safety
25 25 91 91

Similar Stocks

Discover high‑ranked alternatives to IRadimed and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.